The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allergan plc

NYSE: AGN
Last

(U.S.) $244.90

Today's change-1.35 -0.55%
Updated February 28 9:51 AM EST. Delayed by at least 15 minutes.
 

Allergan plc

NYSE: AGN
Last

(U.S.) $244.90

Today's change-1.35 -0.55%
Updated February 28 9:51 AM EST. Delayed by at least 15 minutes.

Allergan plc down (U.S.)$1.35

Allergan plc is lower today, dropping (U.S.)$1.35 or 0.55% to (U.S.)$244.90. Shares have lost 0.91% over the last five days, but have gained 16.61% over the last year to date. This security has underperformed the S&P 500 by 39.22% during the last year.

Key company metrics

  • Open(U.S.) $245.75
  • Previous close(U.S.) $246.25
  • High(U.S.) $246.43
  • Low(U.S.) $244.90
  • Bid / Ask(U.S.) $244.68 / (U.S.) $245.01
  • YTD % change+16.61%
  • Volume182,627
  • Average volume (10-day)2,557,448
  • Average volume (1-month)3,414,715
  • Average volume (3-month)4,682,420
  • 52-week range(U.S.) $184.50 to (U.S.) $299.11
  • Beta1.15
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward15.34×
  • Forward PEG1.13×
  • Indicated annual dividend(U.S.) $2.80
  • Dividend yield1.14%
  • Trailing EPS(U.S.) -$3.12
Updated February 28 9:51 AM EST. Delayed by at least 15 minutes.
S&P TSX0.02%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue3,8643,6223,6853,399
Total other revenue--------
Total revenue3,8643,6223,6853,399
Gross profit3,3853,1603,2432,922
Total cost of revenue480462442477
Total operating expense4,7643,8894,1723,571
Selling / general / administrative1,2771,1571,2101,096
Research & development1,340665905409
Depreciation / amortization1,6391,6091,6331,590
Interest expense (income), net operating--------
Unusual expense (income)29-5-18-2
Other operating expenses, total--------
Operating income-900-266-488-172
Interest income (expense), net non-operating-293-324-346-333
Gain (loss) on sale of assets--------
Other--------
Income before tax-1,111-539-681-501
Income after tax-40-380-423-92
Income tax, total-1,071-159-258-409
Net income-115,220-502256
Total adjustments to net income-70-70-70-70
Net income before extra. items-42-382-424-93
Minority interest-2-2-2-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-112-452-494-163
Inc. avail. to common incl. extra. items-7015,150-571186
Diluted net income-7015,150-571186
Dilution adjustment--------
Diluted weighted average shares357393396395
Diluted EPS excluding extraordinary itemsvalue per share-0.31-1.15-1.25-0.41
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.26-1.16-1.28-0.41